Hims & Hers Health (NYSE:HIMS) shut down Apostrophe on Friday, the skincare business it acquired in 2019 for $190M.
A message at the top of Apostrophe’s website says, “Apostrophe is being discontinued and all current subscriptions will be canceled as of
